Protalix Ltd. – Trademark Portfolio
Entity Type: 03
Protalix Ltd. holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 3 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 4 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include PROCELLEX. The owner is based in Carmiel.
2 Snunit Street, Science Park
Carmiel 2010000 , IL
Showing of trademarks Trademarks
Trademark Classifications
Protalix Ltd.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Scientific and technological services; industrial analysis and research services
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does Protalix Ltd. have?
Protalix Ltd. has 4 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned, 2 cancelled.
What trademark classes does Protalix Ltd. file in?
Protalix Ltd. files trademarks across 4 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 1 (Chemicals), Class 42 (Computer & Scientific), Class 9 (Computers & Electronics). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Protalix Ltd.'s most well-known trademarks?
Protalix Ltd.'s registered trademark portfolio includes well-known marks such as PROCELLEX. These are among 1 currently registered trademark in the portfolio.
What is Protalix Ltd.'s trademark registration success rate?
Protalix Ltd. has a 25% trademark registration rate, with 1 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.